Acquired resistance to EGFR-TKI in an uncommon G719S EGFR mutation

被引：0

作者：

Osoegawa, Atsushi ^{[1
]}

Hashimoto, Takafumi ^{[1
]}

Takumi, Yohei ^{[1
]}

Abe, Miyuki ^{[1
]}

Kobayashi, Ryoji ^{[1
]}

Miyawaki, Michiyo ^{[1
]}

Takeuchi, Hideya ^{[1
]}

Okamoto, Tatsuro ^{[1
]}

Sugio, Kenji ^{[1
]}

机构：

[1] Oita Univ, FOM, Dept Thorac Breast Surg, Oita, Japan

来源：

CANCER SCIENCE | 2018年 / 109卷

关键词：

EGF receptor; PTEN;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-3263

引用

页码：1101 / 1101

页数：1

共 50 条

[1] Acquired Resistance to EGFR-TKI in the Uncommon EGFR Mutation, G719S
Osoegawa, A.
Hashimoto, T.
Takumi, Y.
Kobayashi, R.
Miyawaki, M.
Takeuchi, H.
Okamoto, T.
Sugio, K.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2251 - S2251
[2] Acquired resistance to EGFR-TKI in an uncommon G719S EGFR mutation
Osoegawa, Atsushi
Yamada, Tomonori
Hashimoto, Takafumi
Takumi, Yohei
Kobayashi, Ryoji
Suehiro, Shuji
Miyawaki, Michiyo
Takeuchi, Hideya
Okamoto, Tatsuro
Sugio, Kenji
[J]. CANCER RESEARCH, 2017, 77
[3] Acquired resistance to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in an uncommon G719S EGFR mutation
Atsushi Osoegawa
Takafumi Hashimoto
Yohei Takumi
Miyuki Abe
Tomonori Yamada
Ryoji Kobayashi
Michiyo Miyawaki
Hideya Takeuchi
Tatsuro Okamoto
Kenji Sugio
[J]. Investigational New Drugs, 2018, 36 : 999 - 1005
[4] Acquired resistance to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in an uncommon G719S EGFR mutation
Osoegawa, Atsushi
Hashimoto, Takafumi
Takumi, Yohei
Abe, Miyuki
Yamada, Tomonori
Kobayashi, Ryoji
Miyawaki, Michiyo
Takeuchi, Hideya
Okamoto, Tatsuro
Sugio, Kenji
[J]. INVESTIGATIONAL NEW DRUGS, 2018, 36 (06) : 999 - 1005
[5] Noninvasive analysis of acquired resistance to EGFR-TKI
Kimura, Hideharu
Nishio, Makoto
Daito, Tsutomu
Nishio, Kazuto
[J]. CANCER RESEARCH, 2014, 74 (19)
[6] Different first line EGFR-TKI regimen and the clearance of EGFR sensitive mutation in acquired EGFR-TKI resistant lung adenocarcinoma patients
Zhuang, W.
Xu, C.
Wang, W.
Song, Z.
Zhu, Y.
Chen, R.
Guan, Y.
Yi, X.
Fang, M.
Chen, G.
Lv, T.
Song, Y.
[J]. ANNALS OF ONCOLOGY, 2017, 28
[7] Acquired resistance in NSCLC with EGFR mutation treated with TKI's
Lueers, A.
Hallas, C.
Henke, R. -P
Falk, M.
Tiemann, M.
Griesinger, F.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 6 - 6
[8] Clinical Features and Tumor Immune Microenvironment Related to Acquired Resistance to EGFR-TKI in NSCLC Patients with EGFR Mutation
Zhang, P.
Tu, L.
Liu, R.
Xu, X.
Bao, Z.
Xu, P.
Wang, J.
Li, H.
Zhou, J.
Wang, Y.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S402 - S403
[9] Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation
Izumi, Hiroto
Kanda, Rina
Murakami, Yuichi
Morimoto, Yasuo
Ono, Mayumi
[J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
[10] Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation
Izumi, Hiroto
Kanda, Rina
Murakami, Yuichi
Morimoto, Yasuo
Ono, Mayumi
[J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44

← 1 2 3 4 5 →